Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FTVX1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,583
Award facts
- Contract value 100% obligated
- $12,582.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,582.57 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Zepbound 7.5 mg/0.5 ml pen injections on June 18, 2025, with an ultimate completion date of June 20, 2025. This award was not designated with a set-aside and will be performed in Conshohocken, Pennsylvania. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, leveraged its established position as a critical supplier within the federal pharmaceutical supply chain to secure this order.
This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026, which authorizes the agency to issue firm fixed-price delivery orders for an extensive range of pharmaceutical products supporting military health facilities worldwide. The DMS Pharmaceutical Group contract portfolio demonstrates consistent success in supplying branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites, positioning the company as a key supplier for federal pharmaceutical distribution and pharmacy services.
Quick answers
Who was awarded contract SPE2DB25FTVX1?
SPE2DB25FTVX1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 18, 2025.
How much is contract SPE2DB25FTVX1 worth?
The government has obligated $12,583 on SPE2DB25FTVX1.
Is contract SPE2DB25FTVX1 an order under another contract?
Yes. SPE2DB25FTVX1 is a delivery order under SPE2DB20D6037, an indefinite delivery contract.
Was contract SPE2DB25FTVX1 competed?
The extent of competition for SPE2DB25FTVX1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award